LINC01985: A Potential Drug Target and Biomarker (G101928015)

Target Name: LINC01985

NCBI ID: G101928015

LINC01985

Other Name(s): Long intergenic non-protein coding RNA 1985 | long intergenic non-protein coding RNA 1985

LINC01985: A Potential Drug Target and Biomarker

Long intergenic non-protein coding RNAs (lncNPCRs) have been identified as potential drug targets in various diseases, including cancer. One such lncNPCR, LINC01985, has shown promise as a potential drug target and biomarker in breast cancer.

Expression of LINC01985 has been observed in various breast cancer samples, including primary tumors, metastatic tumors, and normal breast tissue. The expression level of LINC01985 has been shown to be associated with the severity of breast cancer, as well as the overall survival of patients.

In addition to its expression, LINC01985 has also been shown to play a role in the regulation of cell proliferation and apoptosis. Studies have shown that LINC01985 can inhibit the activity of the protein kinase inhibitor PD-L1, which promotes the growth and survival of cancer cells.

Furthermore, LINC01985 has also been shown to be involved in the regulation of the immune response. Studies have shown that LINC01985 can enhance the activity of the T-cell receptor PD-1, which is a key regulator of immune responses.

The potential implications of LINC01985 as a drug target are significant. If LINC01985 can be effectively targeted and inhibited, it may be possible to treat breast cancer effectively and potentially reduce the risk of metastasis.

In addition to its potential as a drug target, LINC01985 has also been shown to be a potential biomarker for breast cancer. The expression of LINC01985 has been shown to be associated with the severity of breast cancer, as well as the overall survival of patients.

Therefore, LINC01985 may be a useful biomarker for the diagnosis and prognosis of breast cancer. Further research is needed to fully understand the potential implications of LINC01985 as a drug target and biomarker for breast cancer.

In conclusion, LINC01985 is a promising lncNPCR that has shown promise as a potential drug target and biomarker in breast cancer. Further research is needed to fully understand its potential implications and to develop effective treatments for this disease.

Protein Name: Long Intergenic Non-protein Coding RNA 1985

The "LINC01985 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01985 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets